Therapeutic roles of a natural herbal product on ameliorating hepatic steatosis via gut dysbacteriosis modulating in treatment of nonalcoholic fatty liver disease in mice
Background: The gut microbiota has well documented as an important player in mediating the development of nonalcoholic fatty liver disease (NAFLD). A patent natural herbal product, compound (Fufang) Zhenzhu Tiaozhi Capsule (FTZ), composed of eight Chinese medical herbs, has prescribed for the preven...
Saved in:
Main Authors: | Xiaoan Ren (Author), Dewei Ye (Author), Wei He (Author), Xiaoqin Wu (Author), Jiao Guo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
by: Jaideep Behari, et al.
Published: (2021) -
Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
by: Xiao-Fang Yang, et al.
Published: (2021) -
Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
by: Asieh Mansour, et al.
Published: (2024) -
Gpr35 shapes gut microbial ecology to modulate hepatic steatosis
by: Xin Wu, et al.
Published: (2023) -
Influence of pancreatic steatosis severity on the course of pediatric nonalcoholic fatty pancreas disease
by: Yu.M. Stepanov, et al.
Published: (2017)